29.08.2014 • NewsMergers & Acquisitions (M&A)AllerganBotox

Delaware Judge Fast-tracks Valeant Suit Over Allergan Meeting

A judge in the US state of Delaware has granted a request by Valeant Pharmaceuticals International and Pershing Square Capital Management, the investment vehicle of activist shareholder Bill Ackman, for expedited proceedings in a dispute over a special meeting dispute with Botox manufacturer Allergan.

Andre Bouchard of Delaware's Court of Chancery has scheduled a three-day trial to start Oct. 6. Allergan had proposed a Nov. 24 trial.

Allergan is the subject of a $52 billion takeover attempt spearheaded by Ackman. The investor is seeking the meeting to try to replace the bulk of Allergan board members with his own slate of directors.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.